Form 4: Macrogenics Director David C. Stump Reports Acquisition of Restricted Stock Units and Stock Options

Director David C. Stump reports acquisition of 6,500 restricted stock units and 16,500 stock options in Macrogenics Inc.

Summary

• On May 21, 2024, David C. Stump, a director of Macrogenics Inc. (MGNX), reported acquiring 6,500 restricted stock units (RSUs) and 16,500 stock options.
• The RSUs will vest one year after the grant date or the day before the next annual meeting, whichever is earlier.
• The stock options will vest in monthly increments over one year, starting one month from the grant date, and are exercisable at a price of $4.26.
• Following these transactions, Mr. Stump directly owns 6,500 RSUs and 16,500 stock options.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of insider transactions. The acquisition of stock options and RSUs can be seen as a positive sign, but it's a routine event.

Positives

• The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder confidence.

Key Dates